UPSC Current Affairs 25 August 2026

 
Contents
1. India’s First Non-GMO Popcorn Maize Hybrid Seed
2. GARBHINI MITRA
3. Dak MITRA and Dak Sewa Apps
4. Crimean-Congo Hemorrhagic Fever (CCHF)
5. Ribociclib
6. Indian Star Tortoise
7. GENESIS EIR 3.0
8. H5N1 Bird flu
 
 
India’s First Non-GMO Popcorn Maize Hybrid Seed

Why in News?
On August 24, 2026, Vice President C. P. Radhakrishnan officially launched India’s first indigenous, non-GMO, high-expansion popcorn maize hybrid seed at Musunuru in Eluru district, Andhra Pradesh.
 

Technical Varieties & Development
  • The Varieties: Two specific hybrid popcorn seed varieties have been launched, named Krisna459 and Godari234.
  • Joint Developers: The seeds were developed locally through a collaborative effort between Gourmet Popcornica and Preferred Popcorn.
  • Natural Breeding: The hybrids were achieved through conventional cross-breeding of selected parent maize plants rather than lab-based genetic engineering.
Operational Advantages
  • High Expansion Ratio: The primary commercial feature is its "high expansion" rate, matching the massive physical popping volume required by multiplexes.
  • Non-GMO Compliance: Being non-Genetically Modified Organism (GMO) means the crop circumvents complex regulatory biotechnology clearances and can go directly to fields.
  • Global Market Premium: European and domestic premium consumer markets value non-GMO labelling, allowing farmers to command higher trade pricing.
Economic and Scale Impact
  • Ending Import Dependence: Historically, India imported premium cinema-grade popcorn seeds and grains from the USA, Argentina, Brazil, and South Africa.
  • Foreign Exchange Savings: Replacing foreign seed imports with a domestic alternative will directly preserve valuable foreign exchange reserves.
  • Massive Scale: The initial cultivation project covers roughly 40,000 acres across 8 Indian states, directly engaging over 17,500 farmers.
 
 
 
GARBHINI MITRA

Why in News?
The All-India Institute of Ayurveda (AIIA), New Delhi, has launched a six-month offline course titled “Garbhini Mitra” for the 2026–27 academic session.
 

Objectives
  • Maternal Support: Train dedicated personnel to provide structured lifestyle guidance, emotional support, and health education to pregnant and postnatal women.
  • Bridge Care Gaps: Create community workers who act as a bridge between households and medical hospitals.
  • Reduce Mortality: Indirectly assist in lowering maternal and infant mortality rates by identifying health complications early.
Details of the Course
  • Duration: It is a six-month offline training programme.
  • Schedule: Classes run from Monday to Friday, between 3:00 PM and 5:00 PM, to accommodate working professionals and caregivers.
  • Batch Size: Limited strictly to 20 students per batch to ensure quality mentorship.
  • Location: Conducted entirely at the AIIA campus in Sarita Vihar, New Delhi.
Key Information
  • Age Requirement: Applicants must be at least 18 years of age.
  • Education: Candidates must have passed the Senior Secondary (10+2) examination from a recognized board, with provisional entry allowed for those awaiting results.
  • Key Areas: Focused on Ayurvedic principles of Garbhini Paricharya (antenatal care), Sutika Paricharya (postnatal care), and practical skills like pregnancy-safe yoga and newborn massage.
  • Safety Protocols: Includes training in basic life support, infection control, and biomedical waste management.
  • Complementary Support: Designed to complement, not replace, modern clinical antenatal care, with a focus on monitoring and facilitating referrals to medical professionals for critical conditions.
  • Graduates can find roles in Ayush centres, NGOs, and community wellness setups, acting as Garbhini Mitra Assistants, prenatal/postnatal care assistants, and maternal health support workers.
 
 
 
Dak MITRA and Dak Sewa Apps

Why in News?
The Dak MITRA and Dak Sewa mobile applications are in the news because they were officially launched in their upgraded, revamped versions on August 24, 2026, by Union Communications Minister Jyotiraditya Scindia and Minister of State Dr. Chandra Sekhar Pemmasani.
 

Dak MITRA App
  • The Dak MITRA (Mobile Interface for Transactions & Rural Assistance) app is an internal tool designed for the postal workforce to streamline operations.
  • Target Users: Exclusively developed for Branch Postmasters (BPMs) and Gramin Dak Sevaks (GDS).
  • Scale of Deployment: Serves as a unified operational platform across more than 1.4 lakh Branch Post Offices nationwide.
  • Device Compatibility: Deployed directly on Android-based handheld devices used by last-mile postal workers.
  • Paperless Transactions: Enables real-time, digital, and completely paperless handling of mail bookings and deliveries.
  • Doorstep Banking & Finance: Empowers staff to offer cash deposits, withdrawals, and Core Banking Services (CBS) directly at the customer's doorstep.
  • Biometric Authentication: Supports Aadhaar-based biometric e-KYC for immediate identity verification.
  • Secure OTP Deliveries: Integrates an OTP-based doorstep delivery system to guarantee secure and verified mail handling.
  • Insurance Premium Collection: Facilitates the collection of premiums for Postal Life Insurance (PLI) and Rural Postal Life Insurance (RPLI).
  • Proven Performance: Since its initial testing phases, it has recorded 2.45 crore Speed Post bookings and collected over β‚Ή5,400 crore in total premiums.
Dak Sewa App
  • The Dak Sewa app is a public-facing application engineered to provide standard postal services directly to Indian citizens.
  • Target Users: Accessible 24/7 to general citizens and retail consumers.
  • Multilingual Inclusivity: Supports 23 Indian languages by integrating the government's BHASHINI AI translation tool.
  • Doorstep Booking: Allows individuals to book Speed Posts, parcels, and money orders right from their home or office.
  • End-to-End Tracking: Provides live tracking of sent articles and instant grievance registration or complaints.
  • Utility Locators: Includes digital tools to locate the nearest Post Office and check active PIN codes.
  • Financial Calculators: Offers built-in calculators to check returns on Post Office savings schemes and interest rates.
  • Digital Payments: Features seamless integration for secure cashless transactions and digital payment modes.
  • Widespread Adoption: The app has already achieved nearly 10 lakh downloads during its trial and testing timeline.
Developing Body & Institutional Background
  • Indigenous Development: Both applications were developed entirely in India by the Centre for Excellence in Postal Technology (CEPT).
  • Modernization Framework: Built on the Advanced Postal Technology (APT) platform under the umbrella of the India Post IT 2.0 Modernization Project.
  • Infrastructure Synergy: The launch coincides with an overhaul of post offices, using a new functional design manual created in partnership with the School of Planning and Architecture (SPA), New Delhi.
 
 
 
Crimean-Congo Hemorrhagic Fever (CCHF)

Why in News?
Scientists have recently identified multiple antibody targets that could lead to the development of the first effective treatments for the Crimean-Congo Hemorrhagic Fever.
 

About CCHF
  • Definition: A severe, potentially fatal zoonotic viral disease that triggers intense hemorrhagic (bleeding) outbreaks in humans.
  • Pathogen: Caused by the Nairovirus (or Orthonairovirus), which belongs to the Bunyaviridae family.
  • Fatality Rate: Extremely lethal, maintaining a high mortality rate ranging between 10% and 40%.
  • History: First discovered in the Crimea in 1944 and later identified in the Congo in 1956. Researchers realized in 1969 that both outbreaks were caused by the exact same virus.
Geographic Distribution
  • Endemic Zones: Frequently spreads across Africa, the Balkans, the Middle East, and Asia.
  • Tick Alignment: Its global presence directly mirrors the geographic range of the Hyalomma tick.
  • Unreported Cases: Public health experts state the true global risk remains poorly defined due to underreporting and misdiagnoses.
Transmission (How it Spreads?)
  • Tick Bites: Primarily transmitted to humans through the bite of infected Hyalomma ticks.
  • Animal Contact: Spread via direct contact with the blood, fluids, or tissues of infected livestock (like cattle, sheep, and goats) during or right after slaughter.
  • Human-to-Human: Spreads between people through close contact with infected blood, bodily secretions, or organs.
  • Hospital Outbreaks: Can spread rapidly in healthcare settings due to poorly sterilized medical equipment or reused needles.
  • High-Risk Groups: Slaughterhouse staff, livestock farmers, veterinarians, and healthcare workers face the highest risk.
Symptoms and Stages
  • Incubation: Lasts 1 to 9 days after a tick bite, or up to 13 days following contact with infected blood.
  • Sudden Onset: Begins abruptly with high fever, severe headache, muscle aches, neck pain, dizziness, and sensitivity to light.
  • Gastrointestinal Distress: Early stages often involve vomiting, nausea, abdominal pain, and non-bloody diarrhea.
  • Hemorrhagic Phase: Rapidly progresses into severe internal and external bleeding, resulting in nosebleeds, large bruises, and uncontrolled bleeding at injection sites.
  • Organ Failure: Can result in fatal complications, including sudden liver failure, kidney failure, and acute nervous system changes like confusion or drowsiness.
Treatment and Prevention
  • No Approved Vaccine: There is currently no safe or effective vaccine available for either humans or animals.
  • Supportive Care: Treatment primarily focuses on symptom management, intensive hydration, and blood product transfusions to manage clotting issues.
  • Antiviral Use: The antiviral drug Ribavirin is frequently used and has shown potential clinical benefits in treating infections.
  • Animal Management: Livestock can be kept in tick-free quarantine zones for 14 days before slaughter to eliminate the risk of transmission.
  • Personal Protection: Individuals in endemic areas are advised to wear protective clothing, use insect repellents, and strictly avoid direct contact with animal fluids.
 
 
 
Ribociclib

Why in News?
Ribociclib is in the news because the Kerala High Court is examining its very high price and accessibility for breast-cancer patients. On 23 August 2026, the court allowed another breast-cancer patient to join a petition concerning the alleged “exorbitant” price of ribociclib.
 

Scientific & Clinical Information
  • Drug Classification: Ribociclib (sold under the brand name Kisqali or Kryxana in India) is a targeted therapy drug belonging to a class called CDK 4/6 inhibitors.
  • Mechanism of Action: It selectively blocks two specific proteins—Cyclin-Dependent Kinase 4 and 6. Overactive CDK 4/6 proteins cause cancer cells to divide rapidly; blocking them stops tumour cell growth and replication.
  • Approved Medical Use: It treats HR-positive (Hormone Receptor) and HER2-negative breast cancers, which make up roughly 70–80% of all breast cancer diagnoses.
  • Target Populations: It is globally approved for adult female and male patients with advanced or metastatic breast cancer, as well as those with early-stage high-risk cancers to prevent recurrence.
  • Dual Administration: Ribociclib is rarely given alone; it is almost always paired with hormone therapies like an aromatase inhibitor or fulvestrant to amplify cancer-fighting efficacy.
  • Recurrence Prevention: Clinical studies like the NATALEE trial demonstrated that combining Ribociclib with endocrine therapy reduces the risk of cancer returning by 25% to 30%.
Administration, Storage, and Side Effects
  • Standard Dosage: For early-stage breast cancer, the typical dosage is 400 mg daily, while metastatic cases use 600 mg. It is taken orally for 21 consecutive days, followed by a 7-day rest period.
  • New Cold-Chain Protocol: Global regulatory reviews by agencies like the U.S. Food and Drug Administration (FDA) mandated that pharmacies store Ribociclib refrigerated until dispensing. Patients can safely keep it at room temperature for up to two months.
  • Primary Side Effects: The most common adverse effect is neutropenia (a drop in white blood cell count), which requires regular laboratory blood monitoring.
  • Other Adverse Effects: Patients may experience gastrointestinal symptoms (nausea, diarrhea), fatigue, hair thinning, temporary liver test abnormalities, or rare heart complications like QT prolongation.
 
 
 
Indian Star Tortoise

Why in News?
On 23 August 2026, 216 Indian Star Tortoises rescued from wildlife-trafficking and illegal-possession cases in Mumbai and Thane were repatriated to the Tadoba–Andhari Tiger Reserve (TATR), Maharashtra.
 

Physical Characteristics
  • Unique Carapace: The black or obsidian upper shell features striking sun-yellow lines radiating outwards like stars, providing perfect natural camouflage.
  • Size Dimorphism: They grow up to 10 inches long, with females being significantly larger than males.
  • Activity Pattern: They are crepuscular, meaning they are primarily active during early mornings and late afternoons.
  • Lifespan: They live a long life spanning 35 to 80 years in their natural wild habitats.
Habitat & Distribution
  • Geographical Range: Endemic to the Indian subcontinent, specifically residing in parts of northwestern India, South India, Pakistan, and Sri Lanka.
  • Indian States: Commonly distributed across dry zones of Odisha, Kerala, Tamil Nadu, Karnataka, Gujarat, and Punjab.
  • Ecosystem Choice: They prefer arid grasslands, semi-arid scrub forests, deciduous pockets, and rocky savannas.
Conservation & Protection Status
  • IUCN Red List: Classified as Vulnerable due to a steadily declining wild population.
  • CITES Status: Listed under Appendix I since 2019, which bans all forms of international commercial trade.
  • Wild Life (Protection) Act, 1972: Upgraded to Schedule I in India, granting it the highest level of legal protection with severe penal sentences for violators.
Primary Threats
  • Illegal Pet Trade: According to the Wildlife Crime Control Bureau (WCCB), 90% of the trade occurs for the global exotic pet market.
  • Superstition & Medicine: They are frequently smuggled into Southeast Asia and East Asia due to beliefs that they bring good luck or possess traditional medicinal values.
  • Habitat Fragmentation: Rapid urbanization and changing agricultural practices are wiping out their specific arid grassland habitats.
  • Unscientific Release: Releasing seized animals without genetic matching causes cross-hybridization, diminishing local evolutionary adaptations.
 
 
 
GENESIS EIR 3.0

Why in News?
The Ministry of Electronics and Information Technology (MeitY), through MeitY Startup Hub (MSH), launched GENESIS Entrepreneur-in-Residence (EIR) Cohort 3, also called GENESIS EIR 3.0.
 

Objective & Framework
  • Umbrella Scheme: It is a core component of India's overarching GENESIS (Gen-Next Support for Innovative Startups) program.
  • Overall Budget: The larger GENESIS parent scheme operates with a total financial outlay of β‚Ή490 crore.
  • The Mission: It bridges the critical funding gap required to convert early-stage technical concepts into pilot-ready, market-viable products.
Key Benefits & Financial Support
  • Direct Grant: Selected fellows receive financial assistance of up to β‚Ή10 lakh via partner incubators.
  • Incubation Access: Complete infrastructure support from participating elite tech hubs across the country.
  • Dedicated Mentorship: One-on-one expert guidance, product validation, Minimum Viable Product (MVP) design, and market commercialisation routes.
Eligible Technology Domains
The program explicitly funds innovations built on Deep Tech and advanced electronic verticals, including:
  • Artificial Intelligence (AI) and Machine Learning (ML)
  • Semiconductors & VLSI Technologies
  • Internet of Things (IoT)
  • Cybersecurity and Blockchain
  • Quantum Technologies
  • Augmented Reality, Virtual Reality (AR/VR), Spatial & Immersive Tech
Strict Eligibility Criteria
  • Target Demographics: Open strictly to Indian citizens who are students, individual innovators, researchers, or early-stage startup founders.
  • Geographical Focus: If a startup is already incorporated, it must be headquartered in a Tier-II or Tier-III city.
  • Company Age: Incorporated entities must be less than two years old at the time of application.
  • Technology Readiness Level (TRL): Inventions must sit firmly between TRL 1–4 (covering early ideation up to prototype/validation stages).
  • No Double Dipping: The applicant must not have received prior financial assistance exceeding β‚Ή10 lakh from any other Central or State government initiative for the same idea.
 
 
 
H5N1 Bird flu

Why in News?
The H5N1 bird flu is recently in the news due to unprecedented global surges in wild birds and poultry, a growing number of human infections linked to livestock contact, and an alarming expansion into mammals.
 

About
  • Definition: H5N1 is a highly pathogenic subtype of the Influenza A virus.
  • Origins: First identified in 1996 in geese in Guangdong, China.
  • Natural Hosts: Wild aquatic birds (like ducks, geese, and swans) are natural asymptomatic reservoirs.
  • Lethality in Birds: While wild birds tolerate it, it is exceptionally lethal to domestic poultry like chickens and turkeys, often carrying a 100% mortality rate.
Transmission & Spread
  • To Animals: Mammals typically catch it by consuming infected bird carcasses or sharing contaminated environments.
  • To Humans: Human infections occur via unprotected direct contact with sick/dead animals, inhaling viral dust/droplets, or touching surfaces covered in infected animal saliva, mucus, or feces.
  • Raw Milk Risk: The virus can survive in high concentrations in raw unpasteurized milk; however, commercial pasteurisation effectively destroys it.
  • Human-to-Human Spread: There is currently no evidence of sustained human-to-human transmission.
Symptoms in Humans
According to the World Health Organization (WHO) and CDC, symptoms range from mild to critical:
  • Mild/Initial: High fever (>38°C), cough, sore throat, fatigue, and muscle aches.
  • Ocular: Red eyes, eye discharge, or conjunctivitis (pink eye) are hallmark signs of current animal-to-human strains.
  • Severe: Shortness of breath, acute severe pneumonia, and respiratory distress.
  • Complications: Sepsis, brain swelling (meningoencephalitis), and multi-organ failure.
  • Mortality: Historically, confirmed human cases have carried a high case-fatality rate exceeding 50%.
Prevention & Public Safety
  • Avoid Dead Wildlife: Do not touch or handle dead or sick wild birds, stray animals, or animal carcasses.
  • Hygiene: Wash hands thoroughly after handling raw poultry meat and avoid visiting bird markets or active poultry farms.
  • Dietary Precautions: Consume only fully cooked poultry products and strictly avoid raw, unpasteurized milk or dairy products.
  • PPE for Workers: Agricultural workers should wear N95 respirators, protective gloves, and safety goggles when handling livestock.
  • Medical Action: If you develop a fever or breathing difficulties after known exposure to poultry or livestock, seek immediate medical care.
 
 
 

Question & Answer
 
Q1. Which two hybrid popcorn maize seed varieties were launched as India’s first indigenous non-GMO varieties?
A) Krisna459 and Godari234
B) Bharat101 and Kaveri202
C) Godari234 and Malhar459
D) Krisna234 and Bharat459
 
Answer: A) Krisna459 and Godari234
 
 
Q2. What is the duration of the “Garbhini Mitra” course launched by AIIA?
A) Three months
B) Six months
C) Nine months
D) One year
 
Answer: B) Six months
 
 
Q3. Which application is designed as an internal tool for Branch Postmasters and Gramin Dak Sevaks?
A) Dak Sewa
B) Dak MITRA
C) India Post
D) Post Connect
 
Answer: B) Dak MITRA
 
 
Q4. Crimean-Congo Hemorrhagic Fever (CCHF) is primarily transmitted through the bite of which tick?
A) Ixodes
B) Dermacentor
C) Hyalomma
D) Rhipicephalus
 
Answer: C) Hyalomma
 
 
Q5. Ribociclib belongs to which class of drugs?
A) ACE inhibitors
B) CDK 4/6 inhibitors
C) Beta blockers
D) Protease inhibitors
 
Answer: B) CDK 4/6 inhibitors

 

Download Pdf
Talk to a Counsellor
DIRECT GUIDANCE

Speak with a Counsellor

Call line: +91 9599-699-007

Request Submitted!

Thank you! Our senior counsellor will connect with you shortly on your number to help guide your UPSC preparation.